| Q57821244 | A New and Simple Risk Predictor of Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention: TIMI Risk Index |
| Q90150705 | A Randomized Double Blind Placebo Controlled Trial Examining the Effects of Pentoxifylline on Contrast Induced Nephropathy Reduction after Percutaneous Coronary Intervention in High Risk Candidates |
| Q94554668 | A comparison between different definitions of contrast-induced acute kidney injury for long-term mortality in patients with acute myocardial infarction |
| Q99635669 | A prediction model of contrast-associated acute kidney injury in patients with hypoalbuminemia undergoing coronary angiography |
| Q79443255 | A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial |
| Q52650262 | A score for decision making during percutaneous coronary intervention in acute myocardial infarction patients with multivessel disease. |
| Q52646003 | ADVANCIS Score Predicts Acute Kidney Injury After Percutaneous Coronary Intervention for Acute Coronary Syndrome. |
| Q44540699 | Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit? |
| Q36836473 | Acute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External Validation |
| Q89912398 | Acute hyperglycemia and contrast-induced nephropathy in patients with non-ST elevation myocardial infarction |
| Q92150016 | Acute kidney injury - A frequent and serious complication after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction |
| Q38727914 | Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity |
| Q48219489 | Acute kidney injury based on the KDIGO criteria among ST elevation myocardial infarction patients treated by primary percutaneous intervention |
| Q90319610 | Acute kidney injury: a common prognostic condition for different pathogenetic triggers? |
| Q44685077 | Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. |
| Q47994820 | Alprostadil plays a protective role in contrast-induced nephropathy in the elderly |
| Q43376058 | An Individually Optimized Protocol of Contrast Medium Injection in Enhanced CT Scan for Liver Imaging. |
| Q43430113 | An invasive management strategy is associated with improved outcomes in high-risk acute coronary syndromes in patients with chronic kidney disease. |
| Q64104458 | Angioplasty with Stenting in Acute Coronary Syndromes with Very Low Contrast Volume Using 6F Diagnostic Catheters and Bench Testing of Catheters |
| Q41628485 | Association Between Acidosis Soon After Reperfusion and Contrast-Induced Nephropathy in Patients With a First-Time ST-Segment Elevation Myocardial Infarction |
| Q90641188 | Association between the risks of contrast-induced nephropathy after diagnostic or interventional coronary management and the transradial and transfemoral access approaches |
| Q40642312 | Association of contrast-induced nephropathy with bare metal stent restenosis in STEMI patients treated with primary PCI. |
| Q53282840 | Association of endothelial microparticle with NO, eNOS, ET-1, and fractional flow reserve in patients with coronary intermediate lesions. |
| Q79445761 | Benefit of acetylcysteine for prevention of contrast-induced nephropathy after primary angioplasty |
| Q46787225 | Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score? |
| Q34574872 | Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction |
| Q37195393 | Chronic kidney disease in acute coronary syndromes |
| Q50577828 | Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study. |
| Q30235510 | Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis |
| Q40785392 | Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention |
| Q58580801 | Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention |
| Q86147381 | Comparison of magnetic wire navigation with the conventional wire technique for percutaneous coronary intervention of chronic total occlusions: a randomised, controlled study |
| Q34438015 | Compound danshen dripping pill pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention |
| Q34005294 | Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry |
| Q92968259 | Contrast induced acute kidney injury and the role of beta-blockers in its prevention |
| Q33599720 | Contrast induced nephropathy in urology |
| Q37922124 | Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines |
| Q45231808 | Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review. |
| Q88868587 | Contrast medium induced acute kidney injury: a narrative review |
| Q43256176 | Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. |
| Q41889016 | Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention |
| Q48720590 | Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention |
| Q47163519 | Contrast-Induced Acute Kidney Injury after Coil Embolization for Aneurysmal Subarachnoid Hemorrhage. |
| Q38701320 | Contrast-Induced Acute Kidney Injury: An Update |
| Q50102438 | Contrast-Induced Nephropathy Is Less Common in Patients with Good Coronary Collateral Circulation |
| Q34155673 | Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention |
| Q39370384 | Contrast-induced acute kidney injury in interventional cardiology: Emerging evidence and unifying mechanisms of protection by remote ischemic conditioning |
| Q38915830 | Contrast-induced acute kidney injury in kidney transplant recipients: A systematic review and meta-analysis |
| Q30777142 | Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy-incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial. |
| Q39327802 | Contrast-induced acute kidney injury: A review of practical points |
| Q38081850 | Contrast-induced acute kidney injury: how much contrast is safe? |
| Q36761998 | Contrast-induced nephropathy following angiography and cardiac interventions |
| Q35193141 | Contrast-induced nephropathy in interventional cardiology |
| Q33929305 | Contrast-induced nephropathy in patients undergoing intravenous contrast-enhanced computed tomography in Korea: a multi-institutional study in 101487 patients |
| Q36576632 | Contrast-induced nephropathy--a review of current literature and guidelines. |
| Q36633516 | Contrast-induced nephropathy: attributable incidence and potential harm |
| Q34566485 | Contrast-induced nephropathy: definition, epidemiology, and patients at risk |
| Q38832758 | Cost-effectiveness of Common Diagnostic Approaches for Evaluation of Asymptomatic Microscopic Hematuria |
| Q43522544 | Derivation and validation of a risk score for contrast-induced nephropathy after cardiac catheterization in Chinese patients |
| Q39684501 | Development of a novel score to predict the risk of acute kidney injury in patient with acute myocardial infarction. |
| Q88499003 | Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction |
| Q39637710 | Differential activation of signaling pathways involved in cell death, survival and inflammation by radiocontrast media in human renal proximal tubular cells. |
| Q51441863 | Does nebivolol prevent contrast-induced nephropathy in humans? |
| Q58386419 | Does the Current Definition of Contrast-induced Acute Kidney Injury Reflect a True Clinical Entity? |
| Q55311894 | Early prediction of contrast-induced acute kidney injury by a "bedside" assessment of Neutrophil Gelatinase-Associated Lipocalin during elective percutaneous coronary interventions. |
| Q28680679 | Early renal dysfunction after contrast media administration despite prophylactic hydration |
| Q64998466 | Early β-blockers administration might be associated with a reduced risk of contrast-induced acute kidney injury in patients with acute myocardial infarction. |
| Q48352293 | Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI. |
| Q58744329 | Effects of body habitus on contrast-induced acute kidney injury after percutaneous coronary intervention |
| Q64286888 | Efficacy of post-procedural oral hydration volume on risk of contrast-induced acute kidney injury following primary percutaneous coronary intervention: study protocol for a randomized controlled trial |
| Q49043462 | Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis |
| Q38863774 | Evaluation of radiological risk during coronary angioplasty procedures: comparison of transradial and transfemoral approaches. |
| Q34080177 | Extended renal outcomes with use of iodixanol versus iohexol after coronary angiography. |
| Q36448320 | Follow-up of patients with contrast-induced nephropathy |
| Q41986241 | Forced diuresis with matched hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): study protocol for a randomized sham-controlled trial |
| Q40315133 | Fragmented QRS complex predicts contrast-induced nephropathy and in-hospital mortality after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction |
| Q47995399 | Gender Difference in the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention |
| Q45043102 | Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group. |
| Q45334831 | Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group |
| Q37360257 | HDL Cholesterol Level Is Associated with Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing PCI. |
| Q37626018 | Heme oxygenase-1 counteracts contrast media-induced endothelial cell dysfunction |
| Q50881789 | High BNP level as risk factor for acute kidney injury and predictor of all-cause mortality in STEMI patients. |
| Q92011895 | High-Sensitivity C-Reactive Protein and Acute Kidney Injury in Patients with Acute Myocardial Infarction: A Prospective Observational Study |
| Q39036982 | Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention |
| Q36478106 | Impact of Chronic Total Occlusion in a Noninfarct-related Artery on Clinical Outcomes in Patients With Acute ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention |
| Q36324396 | Impact of biplane versus single-plane imaging on radiation dose, contrast load and procedural time in coronary angioplasty |
| Q91664549 | Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients |
| Q84965412 | In-hospital prognostic value of hemoglobin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing primary angioplasty |
| Q37039750 | Incidence and Main Determinants of Contrast-Induced Nephropathy following Coronary Angiography or Subsequent Balloon Angioplasty |
| Q38176895 | Incidence and risk of developing contrast-induced acute kidney injury following intravascular contrast administration in elderly patients |
| Q64953393 | Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI. |
| Q48152409 | Irreversible deterioration of estimated glomerular filtration rate in patients with acute myocardial infarction after primary percutaneous coronary intervention. |
| Q90609162 | Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced Computed Tomography for non-traumatic acute abdomen in Emergency Surgery Department? |
| Q37240763 | Kidney Function Does Not Modify the Favorable Quality of Life Changes Associated With Revascularization for Coronary Artery Disease: Cohort Study |
| Q59126005 | Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury |
| Q35645530 | Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases |
| Q30248222 | Multivessel Revascularization Does Not Increase Contrast-Induced Acute Kidney Injury Incidence in Acute Myocardial Infarction: A Meta-Analysis |
| Q64928431 | Negative association between free triiodothyronine level and contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention. |
| Q41425082 | Nephroprotective Effects of L-Carnitine against Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Open-Labeled Clinical Trial |
| Q46389817 | Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial |
| Q38160639 | Neutrophil gelatinase associated lipocalin in acute kidney injury |
| Q44008816 | Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography |
| Q51939887 | Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. |
| Q43688318 | Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention |
| Q52662455 | Non-ST-Segment-Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score-Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management. |
| Q43719161 | Novel risk score of contrast-induced nephropathy after percutaneous coronary intervention |
| Q92408604 | Omega-3 Supplementation in the Prevention of Contrast Induced Nephropathy in Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial |
| Q39200012 | Optical coherence tomography: influence of contrast concentration on image quality and diagnostic confidence |
| Q55080465 | Optimal hydration volume among high-risk patients with advanced congestive heart failure undergoing coronary angiography. |
| Q38323027 | Oral hydration for prevention of contrast-induced acute kidney injury in elective radiological procedures: a systematic review and meta-analysis of randomized controlled trials. |
| Q50275524 | Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium |
| Q46894088 | Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. |
| Q39373204 | Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Stable Angina in Advanced CKD: A Decision Analysis. |
| Q37561885 | Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome |
| Q38682072 | Periprocedural Nebivolol for the Prevention of Contrast-Induced Acute Kidney Injury: A Systematic Review and Meta-analysis |
| Q38363850 | Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: a systematic review and meta-analysis of randomized controlled trials. |
| Q33685017 | Periprocedural hemoglobin drop and contrast-induced nephropathy in percutaneous coronary intervention patients |
| Q37719450 | Post-Hoc Study: Intravenous Hydration Treatment in Chinese Patients with High Risk of Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention |
| Q91709041 | Practical Risk Stratification Score for Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction |
| Q92968235 | Predicting contrast induced nephropathy in patients undergoing percutaneous coronary intervention |
| Q46293344 | Prediction of Contrast-Induced Nephropathy With Persistent Renal Dysfunction and Adverse Long-term Outcomes in Patients With Acute Myocardial Infarction Using the Mehran Risk Score. |
| Q86827097 | Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention |
| Q90194764 | Predictive value of admission D-dimer for contrast-induced acute kidney injury and poor outcomes after primary percutaneous coronary intervention |
| Q33383007 | Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial |
| Q47731151 | Predictors of acute kidney injury in patients admitted with ST-elevation myocardial infarction - results from the Bremen STEMI-Registry |
| Q90683761 | Predictors of contrast-induced acute kidney injury in patients with coronary artery disease receiving contrast agents twice within 30 days |
| Q51344476 | Preprocedural High-Sensitivity C-Reactive Protein Predicts Contrast-Induced Nephropathy and Long-Term Outcome After Coronary Angiography. |
| Q38979950 | Preprocedural Prediction Model for Contrast-Induced Nephropathy Patients |
| Q42874057 | Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease |
| Q38067457 | Prevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review. |
| Q43175944 | Prevention of contrast-induced nephropathy: a single center randomized study. |
| Q54289913 | Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention. |
| Q36077343 | Prognostic Impact of Combined Contrast-Induced Acute Kidney Injury and Hypoxic Liver Injury in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results from INTERSTELLAR Registry. |
| Q90613894 | Quercetin, a Promising Clinical Candidate for The Prevention of Contrast-Induced Nephropathy |
| Q48307298 | Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures |
| Q27021421 | Radiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategies |
| Q37328340 | Relationship Between the Urine Flow Rate and Risk of Contrast-Induced Nephropathy After Emergent Percutaneous Coronary Intervention |
| Q39215652 | Renal Protection Using Remote Ischemic Peri-Conditioning During Inter-Facility Helicopter Transport of Patients With ST-Segment Elevation Myocardial Infarction: A Retrospective Study. |
| Q92419589 | Retinal Vascular Density as A Novel Biomarker of Acute Renal Injury after Acute Coronary Syndrome |
| Q36529372 | Risk factors and therapy strategies for contrast-induced nephropathy |
| Q36481450 | Risk factors for contrast-induced nephropathy |
| Q40350505 | Risk of acute kidney injury associated with neuroimaging obtained during triage and treatment of patients with acute ischemic stroke symptoms |
| Q36925859 | Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study |
| Q26796473 | Risk prediction models for contrast induced nephropathy: systematic review |
| Q43614019 | Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention |
| Q85246984 | ST-elevation myocardial infarction in octogerians |
| Q88871270 | Serum cystatin c is not superior to serum creatinine for early diagnosis of contrast-induced nephropathy in patients who underwent angiography |
| Q93159805 | Serum levels of neutrophil Gelatinase associated Lipocalin (NGAL) predicts hemodialysis after coronary angiography in high risk patients with acute coronary syndrome |
| Q48075549 | Severe liver and renal injuries following cerebral angiography: late life-threatening complications of non-ionic contrast medium administration |
| Q64889504 | Simple pre-procedure risk stratification tool for contrast-induced nephropathy. |
| Q36255696 | Staged versus One-Time Complete Revascularization with Percutaneous Coronary Intervention in STEMI Patients with Multivessel Disease: A Systematic Review and Meta-Analysis |
| Q48714206 | The Effect of Admission Renal Function on the Treatment and Outcome of Patients with Acute Coronary Syndrome. |
| Q93048821 | The association between post-procedural oral hydration and risk of contrast-induced acute kidney injury among ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention |
| Q83451225 | The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention |
| Q94570680 | The conundrum of contrast-induced acute kidney injury |
| Q48368389 | The effect of establishing pre-angiography thresholds on contrast utilization |
| Q50235241 | The efficacy of hemodialysis in interventional therapy in coronary artery disease patients with chronic renal insufficiency |
| Q34523413 | The incidence and prognostic significance of acute kidney injury |
| Q38226255 | The prevention of contrast-induced nephropathy |
| Q36554964 | The relationship between hyperuricemia and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with relatively normal serum creatinine |
| Q43045061 | The risk of acute radiocontrast-mediated kidney injury following endovascular therapy for acute ischemic stroke is low. |
| Q38063188 | The role of N--acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis |
| Q36106130 | The role of neutrophil-gelatinase-associated lipocalin in early diagnosis of contrast nephropathy |
| Q37429288 | Transitioning from 16-slice to 64-slice multidetector computed tomography for the assessment of coronary artery disease: are we really making progress? |
| Q35115570 | Update of acute kidney injury: intensive care nephrology |
| Q30878953 | Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry |
| Q89635188 | Validation of pre-operative risk scores of contrast-induced acute kidney injury in a Chinese cohort |
| Q38604135 | What do small serum creatinine changes tell us about outcomes after acute myocardial infarction? |
| Q44924431 | Zwolle risk score predicts contrast-induced acute kidney injury in STEMI patients undergoing PCI. |
| Q52923652 | [Iodinated contrast agent-induced nephropathy]. |